Press Releases

Global Biodefense Market size was valued at USD 2.6 billion in 2023. It is likely to grow up to USD 4.8 billion by 2030 at a CAGR of 4.2 % during the forecast period ranging between 2025 and 2030.

Technology and tactics used to prevent biological threats are referred to as biodefense. Measuring the risks of germs, viruses, or bioterrorism is also beneficial. In order to support DNA sequencing and immunization, the procedure makes use of cutting-edge technologies including biosensors and quick detection systems. By recognizing prompt responses to epidemics, they also aid in preserving and regaining public health. The world has been made acutely aware of the gravity of biological dangers and the necessity of preparation by global pandemics such as COVID-19. Governments, military agencies, and medical facilities increasingly place a high premium on biological weapons detection, fast reaction capabilities, and pandemic early warning systems. Investments in modern DNA analysis technology, vaccine research, diagnostic kits, and biosensors are growing rapidly. However, limited and uneven global preparedness to deal with biological threats is hindering the market growth.
 
Browse market data Tables and Figures spread through 140 Pages and in-depth TOC on Global Biodefense Market By Product (Vaccines and Antitoxins, Detection Devices, Antibiotics, Masks and PPE, and Decontamination Systems), By Technology (Gene Sequencing, Synthetic Biology, Detection and Surveillance Systems and Immunological Diagnostics), By End User (Military and Defense, Public Health Agencies, Private Labs and Emergency Response Teams), By Type (Detection and Surveillance Systems, Therapeutics, Vaccines And Personal Protective Equipment) and By Geography (North America, Europe, Asia Pacific, Rest of the World) - Forecast from 2025 to 2030.

Global Biodefense Market Segmentation and Key Players

By product, vaccines and antitoxins dominated the global biodefense market. 

Vaccines and antitoxins is the fastest growing segment as it is becoming the main means of protection against both biological attacks and natural epidemics.

"North America dominated the Global Biodefense Market." 

North America is the most dominant region, with the USA leading the way in widespread vaccine development, advanced detection systems and military biosecurity programmes.

Some of the major players in this market are Emergent BioSolutions, SIGA Technologies, Bavarian Nordic, Elusys Therapeutics, Altimmune, DynPort Vaccine Company, Ology Bioservices, Ichor Medical Systems, GSK (GlaxoSmithKline), XOMA Corporation, BioFactura, Soligenix, Sanofi, AstraZeneca

Global Biodefense Market coverage (By Value) 

• Product Insight and Forecast 2025 - 2030
  • Vaccines and Antitoxins
  • Detection Devices
  • Antibiotics
  • Masks and PPE
  • Decontamination Systems

• Technology Insight and Forecast 2025 - 2030
  • Gene Sequencing
  • Synthetic Biology
  • Detection
  • Surveillance Systems
  • Immunological Diagnostics
• End User Insight and Forecast 2025 - 2030
  • Military and Defense
  • Public Health Agencies
  • Private Labs
  • Emergency Response Teams
• Type Insight and Forecast 2025 - 2030
  • Detection and Surveillance Systems
  • Therapeutics
  • Vaccines
  • Personal Protective Equipment

Geographical Segmentation

Global Biodefense Market by Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Vietnam
  • Thailand
  • Malaysia
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries